This award celebrates the supplier with the most citations for products used in cancer research.
Congratulations to Cell Signaling Technology, winners of Supplier Succeeding in Cancer Research award in 2022!
Winning this award really highlights Cell Signaling Technology’s dedication to tackling this disease. Andrew Chalmers, CEO and founder of CiteAb, said ‘Congratulations to Cell Signaling Technology for supporting this extremely important research. Such support will translate into improved outcomes for thousands of patients globally.’
The criteria: At CiteAb we have developed industry leading data collection technology that can identify and understand global reagent use from scientific publications. This data was thoroughly analysed to determine the supplier with the most citations across any reagent type in the area of cancer research.
Explore additional categories featuring in the 2022 CiteAb Awards.